|
| 36318215 | The Dobbs v Jackson Women's Health Organization Supreme Court Decision-Concerns, Challenges, and Consequences for Health Care. | JAMA Surg | 2023 |
| 37750879 | Induced Abortion and the Risk of Rh Sensitization. | JAMA | 2023 |
| 37607986 | Application of a Multiplex Platform to Identify Novel Biomarkers for Pregnancy Location and Viability. | Reprod Sci | 2023 |
| 37495438 | Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]. | Am J Obstet Gynecol | 2023 |
| 37146867 | State restrictions on abortion are associated with fewer abortions in patients with high-risk cardiovascular conditions. | Contraception | 2023 |
| 37467921 | Feasibility and acceptability of virtual group contraceptive counseling prior to abortion care. | Contraception | 2023 |
| 37205488 | Application of a Multiplex Platform to Identify Novel Biomarkers for Pregnancy Location and Viability. | Res Sq | 2023 |
| 37270163 | Evaluation of a decision aid for early pregnancy loss: A pilot randomized controlled trial in Philadelphia, Pennsylvania. | Contraception | 2023 |
| 36966038 | Cervical mucus quality in females with and without cystic fibrosis. | J Cyst Fibros | 2023 |
| 36920399 | Variations in Care for Early Pregnancy Loss Across Clinical Settings. | JAMA Netw Open | 2023 |
| 36701622 | Use of Rh Immune Globulin in First-Trimester Abortion and Miscarriage. | Obstet Gynecol | 2023 |
| 34418379 | Contraceptive use and preferences among females with sickle cell disease. | Contraception | 2022 |
| 35675680 | Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study. | J Womens Health (Larchmt) | 2022 |
| 35675613 | Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss. | Obstet Gynecol | 2022 |
| 35703764 | Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care. | J Acquir Immune Defic Syndr | 2022 |
| 35569516 | Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use. | Am J Obstet Gynecol | 2022 |
| 35780811 | Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration. | Am J Obstet Gynecol | 2022 |
| 35865736 | Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial. | EClinicalMedicine | 2022 |
| 35189928 | Proteome-defined changes in cellular pathways for decidua and trophoblast tissues associated with location and viability of early-stage pregnancy. | Reprod Biol Endocrinol | 2022 |
| 35007872 | Pregnant and bleeding: A model to assess factors associated with the need for emergency care in early pregnancy. | Am J Emerg Med | 2022 |
| 34998653 | Incorporating HIV Pre-Exposure Prophylaxis Care for Patients Seeking Induced Abortion and Pregnancy Loss Management. | Womens Health Issues | 2022 |
| 35272299 | Association of Obesity With Longer Time to Pregnancy. | Obstet Gynecol | 2022 |
| 35192809 | Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks' gestational age: A retrospective cohort study. | Contraception | 2022 |
| 33068612 | Complex family Planning: A newly accredited, landmark fellowship. | Contraception | 2021 |
| 33716075 | Intrauterine device use, sexually transmitted infections, and fertility: a prospective cohort study. | Am J Obstet Gynecol | 2021 |
| 33513267 | Pilot monitoring and evaluation of the WHO postpartum family planning compendium mobile application: An in-depth, qualitative study. | Int J Gynaecol Obstet | 2021 |
| 33895123 | The burden of the Risk Evaluation and Mitigation Strategy (REMS) on providers and patients experiencing early pregnancy loss: A commentary. | Contraception | 2021 |
| 33894252 | Early pregnancy care in North America: A proposal for high-value care that can level health disparities. | Contraception | 2021 |
| 33930380 | The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss. | Contraception | 2021 |
| 34623069 | The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic. | Obstet Gynecol | 2021 |
| 33145775 | Integration of family planning services into health care for HIV-positive women in Botswana. | Int J Gynaecol Obstet | 2021 |
| 33278280 | Racial Disparities in Mental Health Outcomes Among Women With Early Pregnancy Loss. | Obstet Gynecol | 2021 |
| 33160908 | Opioid prescription for pain after osmotic dilator placement in abortion care: A randomized controlled trial. | Contraception | 2021 |
| 33476659 | Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss. | Contraception | 2021 |
| 31563628 | Anticipated Pain During Intrauterine Device Insertion. | J Pediatr Adolesc Gynecol | 2020 |
| 31866516 | Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. | Am J Obstet Gynecol | 2020 |
| 33030869 | Prioritizing Desiredness in Pregnancy of Unknown Location: An Algorithm for Patient-Centered Care. | Obstet Gynecol | 2020 |
| 33196037 | Ultrasound assessment of postplacental copper intrauterine device position 6 months after placement during cesarean delivery. | Contracept X | 2020 |
| 32215633 | Cost-effectiveness of Mifepristone Pretreatment for the Medical Management of Nonviable Early Pregnancy: Secondary Analysis of a Randomized Clinical Trial. | JAMA Netw Open | 2020 |
| 32332396 | In Reply. | Obstet Gynecol | 2020 |
| 32305259 | Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. | Am J Obstet Gynecol | 2020 |
| 32114006 | A simulated patient study to assess referrals to abortion care by student health centers in Pennsylvania. | Contraception | 2020 |
| 32168217 | Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device: Phase 2 Data to 36 Months. | Obstet Gynecol | 2020 |
| 32135125 | The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization. | Contraception | 2020 |
| 32199790 | Pregnancy intentions and contraceptive uptake after miscarriage. | Contraception | 2020 |
| 30470924 | Postpartum contraceptive counseling for first-time adolescent mothers: a randomized controlled trial. | Arch Gynecol Obstet | 2019 |
| 31764740 | Patient Experiences With Miscarriage Management in the Emergency and Ambulatory Settings. | Obstet Gynecol | 2019 |
| 31401994 | It is cost effective to improve the standard of care for women experiencing miscarriage. | Lancet Glob Health | 2019 |
| 31102630 | Fertility considerations and attitudes about family planning among women with cystic fibrosis. | Contraception | 2019 |
| 30739750 | Management of early pregnancy loss, with a focus on patient centered care. | Semin Perinatol | 2019 |